Detalhe da pesquisa
1.
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
Lancet
; 402(10398): 291-303, 2023 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37285865
2.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38634928
3.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37676282
4.
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer.
Future Oncol
; 18(27): 2979-2986, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35950899
5.
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design.
Future Oncol
; 18(4): 425-436, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35080190
6.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 21(12): 1574-1588, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32971005
7.
Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
Oncologist
; 22(3): 286-292, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28220024
8.
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 122(3): 411-9, 2016 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26540173
9.
Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Br J Cancer
; 115(1): 12-9, 2016 06 28.
Artigo
Inglês
| MEDLINE | ID: mdl-27351382
10.
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
J Natl Compr Canc Netw
; 14(7): 820-4, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27407122
11.
10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study.
Oncologist
; 19(5): 507-14, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24755461
12.
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma.
BMC Cancer
; 14: 592, 2014 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25127891
13.
Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis.
Pathol Res Pract
; 253: 154918, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37995423
14.
Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy.
Eur Urol Oncol
; 2024 Jun 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38866640
15.
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
Nat Med
; 30(1): 257-264, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38049622
16.
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.
Cancer Epidemiol Biomarkers Prev
; 33(3): 419-425, 2024 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38189661
17.
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.
J Cancer Res Clin Oncol
; 150(4): 183, 2024 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38594593
18.
Germline EGFR Mutations and Familial Lung Cancer.
J Clin Oncol
; 41(34): 5274-5284, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37579253
19.
Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).
Clin Genitourin Cancer
; 21(3): e104-e113, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36509612
20.
Intercomparison of radiosensitization induced by gold and iron oxide nanoparticles in human glioblastoma cells irradiated by 6 MV photons.
Sci Rep
; 12(1): 9602, 2022 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35688846